Association of deletion allele of insertion/deletion polymorphism in α2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus

Application of Clinical Genetics

Volumn 5, Issue , 2012, Pages 111-118

  Tayel, Safaa I ^a   Khader, Heba F ^a   El Helbawy, Nesreen G ^a   Ibrahim, Waleed A ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

2B adrenoceptor gene; Hypertension; Insertion deletion polymorphism; Type 2 diabetes mellitus

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADRA2B GENE; ADULT; AGE DETERMINATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84870949245     PISSN: 1178704X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-1360.
3. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension Awareness, Treatment, and Control - Continued Disparities in Adults: United States, 2005-2006. Hyattsville, MD: National Center for Health Statistics, NCHS Data Brief 3; 2008.
4. Sorlie D, Stafford RS, Turan TN, et al. Heart Disease and Stroke Statistics - 2011 Update: a report from the American Heart Association. Circulation. 2011;123:e18-e209.
5. Arafa NAS, Ez-Elarab HS. Epidemiology of prehypertension and hypertension among Egyptian adults. The Egyptian Journal of Community Medicine. 2011;29:1-18.
6. Von Wowern F, Bengtsson K, Lindblad U, et al. Functional variant in the 2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension. 2004;43:592-597.
7. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80:53-83.
8. Chen QJ, Lu L, Jin C, et al. Insertion/insertion genotype of α2B-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus. Clin Biochem. 2010;43:1201-1204.
9. Nguyen K, Kassimatis T, Lymperopoulos A. Impaired desensitization of a human polymorphic a2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells. Cell Commun Signal. 2011;9:5.
10. Bylund DB, Eikenberg DC, Hieble JP, et al. IV International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994;46:121-136.
11. Ruffolo RR, Nichols AJ, Stadel JM, Hieble JP. Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol. 1993;33:243-279.
12. Philipp M, Brede M, Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol. 2002;283:R287-R295.
13. Lacey RJ, Chan SL, Cable HC. Expression of alpha 2- and beta-adrenoceptor subtypes in human islets of Langerhans. J Endocrinol. 1996;148:531-543.
14. Siitonen N, Lindstrom J, Eriksson J, et al. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia. 2004;47:1416-1424.
15. Philipp M, Hein L. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther. 2004;101:65-74.
16. Von Wowern F, Bengtsson K, Lindgren CM, et al. A genome wide scan for early onset primary hypertension in Scandinavians. Hum Mol Genet. 2003;12:2077-2081.
17. Rice T, Rankinen T, Province MA. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec Family Study. Circulation. 2000;102:1956-1963.
18. Perola M, Kainulainen K, Pajukanta P. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens. 2000;18:1579-1585.
19. Kristjansson K, Manolescu A, Kristinsson A. Linkage of essential hypertension to chromosome 18q. Hypertension. 2002;39:1044-1049.
20. Suzuki N, Matsunaga T, Nagasumi K. α2b-Adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J Clin Endocrinol Metab. 2003;88: 1184-1187.
21. Dorn GW. Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol Rev. 2010;90:1013-1062.
22. Duerden MG. British Hypertension Society. Guidelines from the British Hypertension Society: BHS is set to bankrupt NHS. BMJ. 2004;329(7465):569-570.
23. Goldstein D, Sacks D, Bruns D. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2007;48:436-472.
24. Wallach J. Metabolic and hereditary disorders. In: Interpretation of Diagnostic Tests. 6th ed. Boston, MA: Little Brown and Company; 1996.
25. Sirchia G, Pizzi C, Scalomogna M. A simple procedure for human lymphocyte isolation from peripheral blood. Tissue Antigens. 1972;72: 138-139.
26. Vasudevan R, Ismail P, Stanslas J, Shamsudin N, Ali AB. Association of insertion/deletion polymorphism of alpha-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian subjects. Int J Biol Sci. 2008;4:362-367.
27. Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Christakidis D, Maltezos E. An insertion/deletion in the alpha 2B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115:327-330.
28. Heinonen P, Koulu M, Pesonen U, Karvonen MK, Rissanen A, Laakso M. Identification of a three-amino acid deletion in the alpha2B adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 1999;84:2429-2433.
29. Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. Effect of a three amino acid deletion in the alpha2B-adrenergic receptor gene on long term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord. 2001;25:1609-1614.
30. Papazoglou D, Papanas N, Papatheodorou K, Kotsiou S, Christakidis D, Maltezos E. An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with age at onset of type 2 diabetes mellitus. Exp Clin Endocronol Diabetes. 2006;114:424-427.
31. Snapir A, Heinonen P, Tuomalainen TP, Alhopuro P, Karvonen MK, Lakka TA. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol. 2001;37:1516-1522.
32. Sivenius K, Niskanen L, Laakso M, Uusitupa M. A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity. Obes Res. 2003;11:962-970.
33. Lockette W, Ghosh S, Farrow S, et al. Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 1995;8: 390-394.
34. Snapir A, Scheinin M, Groop LC, et al. The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes. Cardiovasc Diabetol. 2003;24:2-15.
35. Baldwin CT, Schwartz F, Baima J, et al. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens. 1999;12:853-857.
36. LeRoith D. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med. 2002; 113:3S-11S.
37. Clerk LH, Vincent MA, Lindner JR, Clark MG, Rattigan S, Barrett EJ. The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev. 2004;20:3-12.
38. Talmud PJ, Cooper JA, Gaunt T, et al. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Diabetologia. 2011;54:1710-1719.